Aurinia Pharmaceuticals Inc (AUPH)

Income Tax Expense

$11.37M

Quarterly · Period ending: · USD

AUPH logo

AUPH Income Tax Expense

Latest reported$11.37M
AUPH Quarterly Income Tax (-$132.58K → $11.37M)
High-resolution chart · PNG

AUPH income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc Income Tax Expense — Quarterly (USD)
Period endingIncome Tax Expense (USD)
11,372,000
9,570,000
-175,104,000
411,000
643,000
1,005,000
-256,000
457,000
756,000
739,000
459,000
298,000
-642,000
436,000
855,000
954,000
9,000
10,000
726,000
8,000
18,000
8,000
157,000
-15,000
2,000
-238,000
90,000
25,000
16,000
13,000
73,000
0
0
0
0
0
0
0
0
0
-1,276,000
0
-4,847,000
55,000
0
0
0
0
0
30,000
-3,856,232
-217,143
44,670
24,571
-15,834
0
983
37,084
4,028,324
31,043
-1,033
-2,058
-382,202
3,877
-154,054
-1,697,077
0
-0
193,806
674,744
736,443
149,462
1,965
11,658
10
0
18,310
292,128
1,479,995
-137,425
301,063
793,446
106,271
303,944
0
120,691
455,972
-324,297
-312,791
26,692
1,047,848
-367,647
-233,856
-234,368
-4,555,046
1,318,362
3,756,676
-267,728
2,152
-141,136
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.